|
Solvent |
mg/mL |
mM |
Solubility |
Soluble in DMSO |
0.0 |
100.00 |
Note: There can be variations in solubility for the same chemical from different vendors or different batches from the same vendor. The following factors can affect the solubility of the same chemical: solvent used for crystallization, residual solvent content, polymorphism, salt versus free form, degree of hydration, solvent temperature. Please use the solubility data as a reference only. Warming and sonication will facilitate dissolving. Still have questions? Please contact our Technical Support scientists.
Preparing Stock Solutions
The following data is based on the
product
molecular weight
248.32
Batch specific molecular weights may vary
from batch to batch
due to the degree of hydration, which will
affect the solvent
volumes required to prepare stock solutions.
Concentration / Solvent Volume / Mass |
1 mg |
5 mg |
10 mg |
1 mM |
1.15 mL |
5.76 mL |
11.51 mL |
5 mM |
0.23 mL |
1.15 mL |
2.3 mL |
10 mM |
0.12 mL |
0.58 mL |
1.15 mL |
50 mM |
0.02 mL |
0.12 mL |
0.23 mL |
1: Avila-Carrasco L, Majano P, Sánchez-Toméro JA, Selgas R, López-Cabrera M, Aguilera A, González Mateo G. Natural Plants Compounds as Modulators of Epithelial-to-Mesenchymal Transition. Front Pharmacol. 2019 Jul 30;10:715. doi: 10.3389/fphar.2019.00715. PMID: 31417401; PMCID: PMC6682706.
2: Ma X, Wu K, Xu A, Jiao P, Li H, Xing L. The sesquiterpene lactone eupatolide induces apoptosis in non-small cell lung cancer cells by suppressing STAT3 signaling. Environ Toxicol Pharmacol. 2021 Jan;81:103513. doi: 10.1016/j.etap.2020.103513. Epub 2020 Oct 20. PMID: 33091599.
3: Boldbaatar A, Lee S, Han S, Jeong AL, Ka HI, Buyanravjikh S, Lee JH, Lim JS, Lee MS, Yang Y. Eupatolide inhibits the TGF-β1-induced migration of breast cancer cells via downregulation of SMAD3 phosphorylation and transcriptional repression of ALK5. Oncol Lett. 2017 Nov;14(5):6031-6039. doi: 10.3892/ol.2017.6957. Epub 2017 Sep 15. Erratum in: Oncol Lett. 2018 Jun;15(6):8885. PMID: 29113242; PMCID: PMC5661662.
4: Frey M, Schmauder K, Pateraki I, Spring O. Biosynthesis of Eupatolide-A Metabolic Route for Sesquiterpene Lactone Formation Involving the P450 Enzyme CYP71DD6. ACS Chem Biol. 2018 Jun 15;13(6):1536-1543. doi: 10.1021/acschembio.8b00126. Epub 2018 May 21. PMID: 29758164.
5: Lee J, Tae N, Lee JJ, Kim T, Lee JH. Eupatolide inhibits lipopolysaccharide- induced COX-2 and iNOS expression in RAW264.7 cells by inducing proteasomal degradation of TRAF6. Eur J Pharmacol. 2010 Jun 25;636(1-3):173-80. doi: 10.1016/j.ejphar.2010.03.021. Epub 2010 Mar 28. Erratum in: Eur J Pharmacol. 2013 May 15;708(1-3):139. PMID: 20353767.
6: Boldbaatar A, Lee S, Han S, Jeong AL, Ka HI, Buyanravjikh S, Lee JH, Lim JS, Lee MS, Yang Y. Erratum: Eupatolide inhibits the TGF-β1-induced migration of breast cancer cells via downregulation of SMAD3 phosphorylation and transcriptional repression of ALK5. Oncol Lett. 2018 Jun;15(6):8885. doi: 10.3892/ol.2018.8427. Epub 2018 Apr 4. Erratum for: Oncol Lett. 2017 Nov;14 (5):6031-6039. PMID: 29809196; PMCID: PMC5950548.
7: Kim N, Hwangbo C, Lee S, Lee JH. Eupatolide inhibits PDGF-induced proliferation and migration of aortic smooth muscle cells through ROS-dependent heme oxygenase-1 induction. Phytother Res. 2013 Nov;27(11):1700-7. doi: 10.1002/ptr.4924. Epub 2013 Jan 8. PMID: 23297002.
8: Lee J, Hwangbo C, Lee JJ, Seo J, Lee JH. The sesquiterpene lactone eupatolide sensitizes breast cancer cells to TRAIL through down-regulation of c-FLIP expression. Oncol Rep. 2010 Jan;23(1):229-37. PMID: 19956887.
9: Frey M, Klaiber I, Conrad J, Spring O. CYP71BL9, the missing link in costunolide synthesis of sunflower. Phytochemistry. 2020 Sep;177:112430. doi: 10.1016/j.phytochem.2020.112430. Epub 2020 Jun 6. PMID: 32516579.
10: Lee KH, Huang HC, Huang ES, Furukawa H. Antitumor agents. II. Eupatolide, a new cytotoxic principle from Eupatorium formosanum HAY. J Pharm Sci. 1972 Apr;61(4):629-31. doi: 10.1002/jps.2600610432. PMID: 4335375.